STAGE III RENAL CELL CANCER AJCC V7
Clinical trials for STAGE III RENAL CELL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RENAL CELL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RENAL CELL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets cancer cell recycling in Late-Stage tumors
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs—MK-2206 and hydroxychloroquine—given together to people with advanced solid tumors, melanoma, prostate, or kidney cancer. The goal is to see if blocking a process called autophagy can help kill more cancer cells. …
Matched conditions: STAGE III RENAL CELL CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Immunotherapy combo may keep kidney cancer at bay after surgery
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab to standard kidney cancer surgery can stop the cancer from returning. About 819 people with localized kidney cancer took part. The approach aims to boost the immune system to attack any remaining cancer cells after …
Matched conditions: STAGE III RENAL CELL CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug cocktail shows promise against tough kidney cancer
Disease control OngoingThis study tests a combination of two drugs—entinostat and aldesleukin—for people with kidney cancer that has spread. The goal is to find the safest dose and see if the combo can shrink tumors. About 47 adults with clear cell kidney cancer are taking part.
Matched conditions: STAGE III RENAL CELL CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC